Enzymatic mono-pegylation of glucagon-like peptide 1 towards long lasting treatment of type 2 diabetes

Human glucagon-like peptide-1 (GLP-1) is a physiological gastrointestinal peptide with glucose-dependent insulinotropic effects which is therefore considered an interesting antidiabetic agent. However, after in vivo administration, exogenous GLP-1 does not exert its physiological action due to the c...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Selis, Fabio, Schrepfer, Rodolfo, Sanna, Riccardo, Scaramuzza, Silvia, Tonon, Giancarlo, Dedoni, Simona, Onali, Pierluigi, Orsini, Gaetano, Genovese, Stefano
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4167179/
https://ncbi.nlm.nih.gov/pubmed/25755995
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rinphs.2012.09.001
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak